Literature DB >> 24497223

Tetracycline antibiotics and resistance mechanisms.

Fabian Nguyen, Agata L Starosta, Stefan Arenz, Daniel Sohmen, Alexandra Dönhöfer, Daniel N Wilson.   

Abstract

The ribosome and protein synthesis are major targets within the cell for inhibition by antibiotics, such as the tetracyclines. The tetracycline family of antibiotics represent a large and diverse group of compounds, ranging from the naturally produced chlortetracycline, introduced into medical usage in the 1940s, to second and third generation semi-synthetic derivatives of tetracycline, such as doxycycline, minocycline and more recently the glycylcycline tigecycline. Here we describe the mode of interaction of tetracyclines with the ribosome and mechanism of action of this class of antibiotics to inhibit translation. Additionally, we provide an overview of the diverse mechanisms by which bacteria obtain resistance to tetracyclines, ranging from efflux, drug modification, target mutation and the employment of specialized ribosome protection proteins.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24497223     DOI: 10.1515/hsz-2013-0292

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  100 in total

1.  Structural characterization of an alternative mode of tigecycline binding to the bacterial ribosome.

Authors:  Andreas Schedlbauer; Tatsuya Kaminishi; Borja Ochoa-Lizarralde; Neha Dhimole; Shu Zhou; Jorge P López-Alonso; Sean R Connell; Paola Fucini
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

2.  Molecular Biology Methods in Streptomyces rimosus, a Producer of Oxytetracycline.

Authors:  Lucija Slemc; Špela Pikl; Hrvoje Petković; Martina Avbelj
Journal:  Methods Mol Biol       Date:  2021

3.  Cryo-EM structure of the tetracycline resistance protein TetM in complex with a translating ribosome at 3.9-Å resolution.

Authors:  Stefan Arenz; Fabian Nguyen; Roland Beckmann; Daniel N Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

Review 4.  Ribosome protection by ABC-F proteins-Molecular mechanism and potential drug design.

Authors:  Rya Ero; Veerendra Kumar; Weixin Su; Yong-Gui Gao
Journal:  Protein Sci       Date:  2019-03-04       Impact factor: 6.725

Review 5.  Target protection as a key antibiotic resistance mechanism.

Authors:  Daniel N Wilson; Vasili Hauryliuk; Gemma C Atkinson; Alex J O'Neill
Journal:  Nat Rev Microbiol       Date:  2020-06-25       Impact factor: 60.633

Review 6.  Bacterial Protein Synthesis as a Target for Antibiotic Inhibition.

Authors:  Stefan Arenz; Daniel N Wilson
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

Review 7.  Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2019-09-21       Impact factor: 4.411

8.  Enhanced Molecular Typing of Treponema pallidum subspecies pallidum Strains From 4 Italian Hospitals Shows Geographical Differences in Strain Type Heterogeneity, Widespread Resistance to Macrolides, and Lack of Mutations Associated With Doxycycline Resistance.

Authors:  Lorenzo Giacani; Giulia Ciccarese; Christian Puga-Salazar; Ivano Dal Conte; Laura Colli; Marco Cusini; Stefano Ramoni; Sergio Delmonte; Antonietta DʼAntuono; Valeria Gaspari; Francesco Drago
Journal:  Sex Transm Dis       Date:  2018-04       Impact factor: 2.830

9.  Multiple mutations and increased RNA expression in tetracycline-resistant Streptococcus pneumoniae as determined by genome-wide DNA and mRNA sequencing.

Authors:  Andréanne Lupien; Hélène Gingras; Michel G Bergeron; Philippe Leprohon; Marc Ouellette
Journal:  J Antimicrob Chemother       Date:  2015-04-09       Impact factor: 5.790

Review 10.  Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

Authors:  George G Zhanel; Doris Cheung; Heather Adam; Sheryl Zelenitsky; Alyssa Golden; Frank Schweizer; Bala Gorityala; Philippe R S Lagacé-Wiens; Andrew Walkty; Alfred S Gin; Daryl J Hoban; James A Karlowsky
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.